top of page
color cloud.png
no pic.jpg
no pic.jpg

Keren Tzarfaty

MAPS Israel & Hakomi Institute Israel

Keren Tzarfaty, Keren Tzarfaty, Ph.D, MFT is the cofounder of MAPS Israel (Multidisciplinary Association for Psychedelic Studies) and the co-founder of the Hakomi Institute of Israel, a Hakomi Trainer and a senior educator for MAPS. She is a clinical investigator in the MDMA PTSD FDA-approved clinical trial, examining the impact of MDMA-assisted psychotherapy on severe PTSD patients. She is also one of the founder of the new MA program at Haifa University: Integrative psychotherapy: Body, Mind, spirit.

Keren holds an MA in Somatic Psychology and a Ph.D. in East- West Psychology, both from the California Institute of Integral Studies in San Francisco. She specializes in integrating mindfulness-based psychodynamic psychotherapy with somatic psychotherapy, attachment psychotherapy, trauma psychology and transpersonal psychology. Her approach is grounded in traditional western psychologies as well as inspired by Eastern and Shamanic spiritual traditions.

color cloud.png

Stay Up to Date

Never miss a deadline. Get the latest to your inbox. 

Thanks for subscribing!

About Psychedelic Medicine – Israel 2024

With the rediscovery of psychedelic drugs as potential treatments for psychiatric disorders, we may be on the verge of the next revolution. The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction and pain medicine are among the potential beneficiaries along with inflammatory and possibly autoimmune disorders. 

Conference Organizer
Screen Shot 2022-10-23 at 20.47.10.png

© Target Conferences 2022, All rights reserved.

Terms And Conditions

Privacy Policy

bottom of page